Jinhe Biotechnology (China) Performance
| 002688 Stock | 6.11 0.10 1.66% |
The company retains a Market Volatility (i.e., Beta) of 0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Jinhe Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Jinhe Biotechnology is expected to be smaller as well. At this point, Jinhe Biotechnology has a negative expected return of -0.24%. Please make sure to check out Jinhe Biotechnology's coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if Jinhe Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Jinhe Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Forward Dividend Yield 0.0166 | Payout Ratio 0.5981 | Last Split Factor 25:10 | Forward Dividend Rate 0.1 | Ex Dividend Date 2025-06-06 |
1 | Luoyang Xinqianglian Leads High-Performing Stocks with 130.68 percent Return - Markets Mojo | 11/04/2025 |
| Begin Period Cash Flow | 497.6 M |
Jinhe |
Jinhe Biotechnology Relative Risk vs. Return Landscape
If you would invest 709.00 in Jinhe Biotechnology Co on August 28, 2025 and sell it today you would lose (98.00) from holding Jinhe Biotechnology Co or give up 13.82% of portfolio value over 90 days. Jinhe Biotechnology Co is generating negative expected returns and assumes 1.9529% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Jinhe, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jinhe Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jinhe Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jinhe Biotechnology Co, and traders can use it to determine the average amount a Jinhe Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1215
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 002688 |
Estimated Market Risk
| 1.95 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Jinhe Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jinhe Biotechnology by adding Jinhe Biotechnology to a well-diversified portfolio.
Jinhe Biotechnology Fundamentals Growth
Jinhe Stock prices reflect investors' perceptions of the future prospects and financial health of Jinhe Biotechnology, and Jinhe Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jinhe Stock performance.
| Return On Equity | 0.0415 | ||||
| Return On Asset | 0.0267 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 6.3 B | ||||
| Shares Outstanding | 771.63 M | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 2.37 B | ||||
| Gross Profit | 867.44 M | ||||
| EBITDA | 435.95 M | ||||
| Net Income | 100.2 M | ||||
| Total Debt | 1.03 B | ||||
| Book Value Per Share | 3.05 X | ||||
| Cash Flow From Operations | 498.42 M | ||||
| Earnings Per Share | 0.16 X | ||||
| Total Asset | 5.65 B | ||||
| Retained Earnings | 576.82 M | ||||
About Jinhe Biotechnology Performance
By analyzing Jinhe Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Jinhe Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jinhe Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jinhe Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Jinhe Biotechnology is entity of China. It is traded as Stock on SHE exchange.Things to note about Jinhe Biotechnology performance evaluation
Checking the ongoing alerts about Jinhe Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jinhe Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jinhe Biotechnology generated a negative expected return over the last 90 days | |
| About 36.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Luoyang Xinqianglian Leads High-Performing Stocks with 130.68 percent Return - Markets Mojo |
- Analyzing Jinhe Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jinhe Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Jinhe Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jinhe Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jinhe Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jinhe Biotechnology's stock. These opinions can provide insight into Jinhe Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jinhe Stock analysis
When running Jinhe Biotechnology's price analysis, check to measure Jinhe Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jinhe Biotechnology is operating at the current time. Most of Jinhe Biotechnology's value examination focuses on studying past and present price action to predict the probability of Jinhe Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jinhe Biotechnology's price. Additionally, you may evaluate how the addition of Jinhe Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |